47 The multi-faceted extracellular matrix: unlocking its secrets for understanding the perpetuation of lung fibrosis 51. Bellaye PS, Shimbori C, Upagupta C, Sato S, Shi W, Gauldie J, Ask K, Kolb M. Lysyl Oxidase-Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-beta1-induced Pulmonary Fibrosis. Am J Respir Cell Mol Biol 2018: 58(4): 461470. 52. Wolters PJ, Chapman HA. Importance of lysosomal cysteine proteases in lung disease. Respir Res 2000: 1(3): 170-177. 53. Mahalanobish S, Saha S, Dutta S, Sil PC. Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis. Pharmacol Res 2020: 152: 104591. 54. Chakraborti S, Sarkar J, Pramanik PK, Chakraborti T. Role of Proteases in Lung Disease: A Brief Overview. Proteases in Human Diseases Proteases in Human Diseases. Springer Singapore, 2017; pp. 333-374. 55. Askew DJ, Silverman GA. Intracellular and extracellular serpins modulate lung disease. J Perinatol 2008: 28 Suppl 3(Suppl 3): S127135. 56. Buhling F, Waldburg N, Reisenauer A, Heimburg A, Golpon H, Welte T. Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. Eur Respir J 2004: 23(4): 620-628. 57. Pardo A, Cabrera S, Maldonado M, Selman M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir Res 2016: 17(1): 23. 58. Craig VJ, Zhang L, Hagood JS, Owen CA. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2015: 53(5): 585600. 59. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 2008: 40(6-7): 13341347. 60. Butler GS, Overall CM. Matrix metalloproteinase processing of signaling molecules to regulate inflammation. Periodontol 2000 2013: 63(1): 123-148. 61. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004: 4(8): 617-629. 62. Shiomi T, Lemaître V, D’Armiento J, Okada Y. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int 2010: 60(7): 477-496. 63. Morais A, Beltrão M, Sokhatska O, Costa D, Melo N, Mota P, Marques A, Delgado L. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias. Respir Med 2015: 109(8): 1063-1068. 64. Pardo A, Selman M, Kaminski N. Approaching the degradome in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008: 40(67): 1141-1155. 65. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, Lollini L, Morris D, Kim Y, DeLustro B, Sheppard D, Pardo A, Selman M, Heller RA. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002: 99(9): 6292-6297. 2
RkJQdWJsaXNoZXIy MTk4NDMw